The Reliability of Ultrasound Markers in Identifying Fetuses With a Life‐Limiting Skeletal Dysplasia
Prenatal Diagnosis · 2024
DOI: 10.1002/pd.6638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2024. Verfasst von Haley M Crane und 9 weiteren Autor:innen. Beteiligte Einrichtung: Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Ultrasonography, Prenatal, Bone Diseases, Developmental. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To determine the diagnostic performance of ultrasound markers associated with life‐limiting fetal skeletal dysplasia in a fortified cohort.
Methods
Retrospective review from 2013 to 2023 of pregnancies with suspected fetal skeletal dysplasia. Ultrasound evaluation included measurements predictive of a life‐limiting dysplasia: thoracic circumference/abdominal circumference (TC/AC) < 0.6, femur length/abdominal circumference (FL/AC) < 0.16, and thoracic circumference (TC) < 2.5th percentile. Demographics, ultrasound findings, genetic testing, and fetal/neonatal outcome were reviewed.
Results
Of 96 fetuses with complete outcome data, 47 (49%) had a non‐life‐limiting dysplasia and 49 (51%) had a life‐limiting dysplasia. 22 (23%) had no life‐limiting markers, 42 (44%) had one, 27 (28%) had two, and 5 (5%) had three. FL/AC < 0.16 and TC < 2.5th percentile were associated with life‐limiting dysplasia ( p < 0.001; p < 0.001), while TC/AC < 0.6 was rare and did not reach statistical significance ( p = 0.056). The positive predictive value (PPV) for predicting life‐limiting dysplasia increased from 50% to 78% to 100% with one, two, or three markers. The PPV of the two life‐limiting markers was significantly higher in those diagnosed at < versus ≥ 28 weeks (90% vs. 43%, p = 0.02) but the analysis was limited by small numbers in the ≥ 28 weeks cohort. The negative predictive value of no life‐limiting markers was 91%.
Conclusions
In our cohort, the presence of two life‐limiting ultrasound markers prior to 28 weeks was highly suggestive of a life‐limiting dysplasia, whereas the absence of life‐limiting markers was strongly associated with a non‐life‐limiting dysplasia throughout gestation. Nonetheless, individual markers had a poor predictive value of lethality, and a life‐limiting diagnosis ≥ 28 weeks is challenging based on ultrasound markers alone. This highlights the importance of integrating thorough sonography, genetic testing, and balanced parental counseling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Radiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Haley M Crane, Shelly Soni, Juliana Gebb
Zitieren
APA
Crane, H. M., Schindewolf, E., Burrill, N., Debari, S., Khalek, N., Paidas Teefey, C., Soni, S., Coleman, B., Moldenhauer, J. S., & Gebb, J. (2024). The Reliability of Ultrasound Markers in Identifying Fetuses With a Life‐Limiting Skeletal Dysplasia. Prenatal Diagnosis. https://doi.org/10.1002/pd.6638
Vancouver
Crane HM, Schindewolf E, Burrill N, Debari S, Khalek N, Paidas Teefey C, et al. The Reliability of Ultrasound Markers in Identifying Fetuses With a Life‐Limiting Skeletal Dysplasia. Prenatal Diagnosis. 2024. doi:10.1002/pd.6638
BibTeX
@article{Crane2024,
author = {Crane, Haley M and Schindewolf, Erica and Burrill, Natalie and Debari, Suzanne and Khalek, Nahla and Paidas Teefey, Christina and Soni, Shelly and Coleman, Beverly and Moldenhauer, Julie S and Gebb, Juliana},
title = {The Reliability of Ultrasound Markers in Identifying Fetuses With a Life‐Limiting Skeletal Dysplasia},
journal = {Prenatal Diagnosis},
year = {2024},
doi = {10.1002/pd.6638}
}
EUVIMED